will semaglutide be discontinued An Ongoing Crisis: Shortage Raises Dual Concerns for Obesity and Diabetes Treatment Will Compounded Semaglutide Be Discontinued?

Media Contact: Justine Sessions [email protected] 860-810-6523 SOURCE Evernorth

AsGGT2-5-RACE-RT (5-[Phos]TGAGCTCGTAA ACTC-3), AsGGT2-5-RACE-F1 (5-TGTGCGACGGTATCCG ATCA-3), AsGGT2-5-RACE-F2 (5-CTCAATCCAATTCAACCT AGAC-3), AsGGT2-5-RACE-R1 (5-CATTGTGCAGCGGACGA TAG-3), and AsGGT2-5-RACE-R2 (5-GGTTCCATTAATGTGG AGGAG-3) for AsGGT2

Both medications share similar side effect profiles with Tirzepatide showing slightly better tolerability

wherein X is Boc or Trt Fragment-2: Fmoc-Thr(tBu)-Phe-Thr(tBu)-Ser(tBu)-Asp(OtBu)-Val-Ser(Oxa)-OH Fragment-3: Fmoc-Ser(tBu)-Tyr(tBu)-Leu-Glu(OtBu)-Gly-OH Fragment-4: Fmoc-Gln(Trt)-Ala-Ala-Lys(PEG-PEG-Y-Glu-octadecane dioic acid)-Glu(OtBu)- Phe-Ile-Ala-Trp(Boc)-OH Fragment-5: Leu-Val-Arg(pbf)-Gly-Arg(pbf)-Gly-OtBu Fragment-6: H-Gln(Trt)-Ala-Ala-Lys(C18diacidmono-t-butyl-Y-Glu(AEEA-AEEA)-OtBu)- Glu(OtBu)-Phe-Ile-Ala-Trp (Boc)-Leu-Val-Arg(Pbf)-Gly-Arg(Pbf)-Gly-OtBu Fragment-7: Boc-His(X)-Aib-Glu(OtBu)-Gly-Thr(tBu)-Phe-Thr(tBu)-Ser(tBu)-Asp(OtBu)- Val-Ser(Oxa)-OH

The most common side effects remain mild and localized, primarily involving injection site reactions that resolve spontaneously